Rentokil price target lowered to GBP4.40 by RBC Capital on workwear sale

RBC Capital lowered its price target on Rentokil Initial to GBP4.40 from GBP4.50, maintaining an Outperform rating despite near-term headwinds including challenging North American trading conditions and CEO transition uncertainty. The firm expects a 4% EPS impact from the French Workwear disposal but remains optimistic about Rentokil's long-term prospects, citing fixable issues and significant re-rating potential, while Berenberg and Bernstein SocGen downgraded the stock citing concerns over leadership and strategic direction in North America, with EPS estimates 6-15% below consensus.

Analysis

Rentokil Initial Plc. (RTO) presents a complex investment case, marked by divergent analyst outlooks and significant operational crosscurrents. RBC Capital recently lowered its price target to GBP4.40 from GBP4.50, attributing the adjustment to an expected 4% impact on FY26E earnings per share from the French Workwear disposal, yet maintained an "Outperform" rating, citing "fixable" issues and "significant re-rating potential over time," partly due to a perceived lack of large-cap value opportunities elsewhere in the sector. This contrasts sharply with downgrades from Berenberg (to Sell) and Bernstein SocGen (to Underperform), both setting a £3.00 price target and voicing concerns over leadership, strategic direction, and challenges in the U.S. Pest segment. The company, currently trading at $23.80 with a $12 billion market capitalization and impressive 84% gross profit margins according to InvestingPro, faces several near-term headwinds: challenging Q2 trading conditions anticipated in North America, uncertainty around its revised TMX integration plan, and a critical leadership transition. CEO Andy Ransom is set to retire by 2026, and searches are underway for both a new Group CEO and a North America CEO. Further complicating the outlook are analyst concerns regarding earnings quality, including a reliance on one-time revenues and strategic shifts in store numbers and branding, which have led to some earnings per share estimates falling 6-15% below consensus. While InvestingPro analysis suggests the stock may be undervalued, with general analyst price targets cited between $28 and $32, the prevailing sentiment is cautious due to these multifaceted challenges.

Key Decisions for Investors

• Investors should closely monitor upcoming announcements regarding the new Group CEO and North America CEO, as these appointments will be pivotal for strategic clarity and addressing operational issues, particularly in North America.
• A cautious approach is advisable given the conflicting analyst ratings and identified headwinds; focus on Q2 North American trading performance and updates on the TMX integration plan for signs of stabilization or further challenges.
• Weigh the company's robust 84% gross profit margins and potential undervaluation, as suggested by InvestingPro, against the material risks posed by leadership transitions, strategic uncertainties, and earnings quality concerns before adjusting positions.